MoonLake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phas…

Biotechnology

CH, Zug [HQ]

Government, Law & Regulation

Government Awards Analysis Beta

It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company. The Data for the government spending analysis is directly sourced from the US gov. application interface.

Obligations Over-Time

Awards

Obligations

MoonLake Immunotherapeutics has no obligation with a government/award agency.

Latest Obligations

Contracts

$ 0.0

0.0 IDVs

$ 0.0

Direct Payments

$ 0.0

Grants

$ 0.0

Loans

$ 0.0

Other Payments

$ 0.0

vs. Previous FY

Contracts

$ 0.0

IDVs

$ 0.0

Direct Payments

$ 0.0

Grants

$ 0.0

Loans

$ 0.0

Other Payments

$ 0.0

YoY Trends

No trends presentable at the moment.

Spending By Type

Awards

Obligations

Contracts IDV Contracts Grants Loans Direct Other

MoonLake Immunotherapeutics can't present spending by time.

Contract Analysis

Palmy tracks high-doted primary awards as well as their sub contracts on a regular basis.
This empowers you to dive deeper to unveil recent changes, risks and products/services MoonLake Immunotherapeutics offers.

There are no contract award details available for MoonLake Immunotherapeutics